CELEX: 32009M5713
Language: en
Date: 2009-12-11 00:00:00
Title: Commission Decision of 11/12/2009 declaring a concentration to be compatible with the common market (Case No COMP/M.5713 - ALTOR  / PHARMACY COMPANY SWEDEN 1 AB and PHARMACY COMPANY SWEDEN 8 AB) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|

32009M5713

Commission Decision of 11/12/2009 declaring a concentration to be compatible with the common market (Case No COMP/M.5713 - ALTOR  / PHARMACY COMPANY SWEDEN 1 AB and PHARMACY COMPANY SWEDEN 8 AB) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)  

Official Journal 0305 , 16/12/2009 P. 0006 - 0006

          |EUROPEAN COMMISSION     |
            Brussels , 11.12.2009
             SG-Greffe(2009) D/11137
             C(2009) 10247
             PUBLIC VERSION
             MERGER PROCEDURE ARTICLE 6(1)(b) DECISION
             SIMPLIFIED PROCEDURE
             To the notifying party:  
             Dear Madam(s) and/or Sir(s),
             Subject: Case No COMP/M.5713 – ALTOR/ PHARMACY COMPANY SWEDEN 1 AB and PHARMACY COMPANY SWEDEN 8 AB. Notification of 13/11/2009 pursuant to Article 4 of Council Regulation (EC) No 139/2004  [1]  Publication in the Official Journal of the European Union No C 280, 20/11/2009, p. 32
            1.  On 13/11/2009, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which Altor Fund III GP Limited (as General Partner of Altor Fund III (No. 1) Limited Partnership, Altor Fund III (No. 2) Limited Partnership and as investment manager to Altor Fund III (No. 3) Limited, Channel Islands) acquires, within the meaning of Article 3(1)(b) of the Council Regulation, by way of purchase of shares, sole control of Pharmacy Company Sweden 1 AB and Pharmacy Company Sweden 8 AB (Sweden).
            2.  The business activities of the undertakings concerned are:
              - Altor Fund III is a private equity investment fund.
              - Pharmacy Company Sweden 1 AB and Pharmacy Company 8 AB are two clusters of pharmacies and pharmacy shops located in Sweden. 
             3. After examination of the notification, the Commission has concluded that the notified operation falls within the scope of Council Regulation (EC) No 139/2004 and of paragraph 5(c) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2]  .
             4. For the reasons set out in the Notice on a simplified procedure, the Commission has decided not to oppose the notified operation and to declare it compatible with the common market and with the EEA Agreement.  This decision is adopted in application of Article 6(1)(b) of Council Regulation (EC) No 139/2004.
             For the Commission (signed) Philip LOWE Director General
            [1] OJ L 24, 29.1.2004, p. 1.
            [2] OJ C 56, 05.3.2005, p. 32.